Localized delivery of nanomedicine and antibodies for combating COVID-19.

Tu, Bin; Gao, Yanrong; An, Xinran; Wang, Huiyuan; Huang, Yongzhuo

Tu, Bin; Gao, Yanrong; An, Xinran; Wang, Huiyuan; Huang, Yongzhuo.

Afiliación

Tu B; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Gao Y; University of Chinese Academy of Sciences, Beijing 100049, China.
An X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Wang H; University of Chinese Academy of Sciences, Beijing 100049, China.
Huang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

Acta Pharm Sin B ; 13(5): 1828-1846, 2023 May.

Article en En | MEDLINE | ID: mdl-36168329

Palabras clave

Antibody; COVID-19; Intranasal delivery; Nanomedicine; Orally-inhaled delivery; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Acta Pharm Sin B Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google